Global Medical REIT Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Global Medical REIT stock.
View analyst ratings for Global Medical REIT or view top-rated stocks.

Wall Street analysts have given Global Medical REIT a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Global Medical REIT wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Global Medical REIT saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 990,000 shares, an increase of 70.7% from the June 15th total of 579,900 shares. Based on an average daily volume of 524,400 shares, the days-to-cover ratio is currently 1.9 days. Currently, 1.7% of the company's stock are short sold.
View Global Medical REIT's Short Interest.

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Global Medical REIT.

Global Medical REIT will be holding an earnings conference call on Wednesday, August 4th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13721115".

Global Medical REIT Inc. (NYSE:GMRE) issued its earnings results on Wednesday, May, 5th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by $0.19. Global Medical REIT had a negative trailing twelve-month return on equity of 0.89% and a negative net margin of 3.67%.
View Global Medical REIT's earnings history.

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GMRE shares have increased by 25.6% and is now trading at $15.59.
View which stocks have been most impacted by COVID-19.

Global Medical REIT declared a quarterly dividend on Friday, June 11th. Shareholders of record on Thursday, June 24th will be paid a dividend of $0.205 per share on Thursday, July 8th. This represents a $0.82 annualized dividend and a yield of 5.26%. The ex-dividend date of this dividend is Wednesday, June 23rd.
View Global Medical REIT's dividend history.

Global Medical REIT pays an annual dividend of $0.82 per share and currently has a dividend yield of 5.34%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Global Medical REIT does not yet have a strong track record of dividend growth. The dividend payout ratio of Global Medical REIT is 93.18%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 78.10% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.
View Global Medical REIT's dividend history.

4 Wall Street analysts have issued 12 month price objectives for Global Medical REIT's stock. Their forecasts range from $15.00 to $18.00. On average, they expect Global Medical REIT's share price to reach $16.75 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price.
View analysts' price targets for Global Medical REIT or view top-rated stocks among Wall Street analysts.

Some companies that are related to Global Medical REIT include Broadstone Net Lease (BNL), Lexington Realty Trust (LXP), PotlatchDeltic (PCH), Essential Properties Realty Trust (EPRT), Outfront Media (OUT), Corporate Office Properties Trust (OFC), Chimera Investment (CIM), Keppel REIT (KREVF), DigitalBridge Group (DBRG), Apple Hospitality REIT (APLE), Equity Commonwealth (EQC), SITE Centers (SITC), National Health Investors (NHI), Safestore (SFSHF) and The Macerich (MAC).
View all of GMRE's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Square (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Global Medical REIT's stock is owned by a number of retail and institutional investors. Top institutional investors include Sound Income Strategies LLC (0.29%), Hodges Capital Management Inc. (0.08%) and State of Alaska Department of Revenue (0.04%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends for Global Medical REIT.

GMRE stock was bought by a variety of institutional investors in the last quarter, including Sound Income Strategies LLC, Hodges Capital Management Inc., and State of Alaska Department of Revenue. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, and Ronald Marston.
View insider buying and selling activity for Global Medical REIT or or view top insider-buying stocks.

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GMRE stock can currently be purchased for approximately $15.59.

Global Medical REIT has a market capitalization of $947.72 million and generates $93.73 million in revenue each year. The company earns $-1,920,000.00 in net income (profit) each year or $0.88 on an earnings per share basis.

Global Medical REIT employs 22 workers across the globe.

The official website for Global Medical REIT is www.globalmedicalreit.com.

Global Medical REIT is headquartered at 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814.

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851 or via email at [email protected]